Abnormal Cerebrovascular Activity, Perfusion, and Glymphatic Clearance in Lewy Body Diseases

Sephira G Ryman*, Andrei A Vakhtin, Andrew R Mayer, Harm Jan van der Horn, Nicholas A Shaff, Stephanie R Nitschke, Kayla R Julio, Rawan M Tarawneh, Gary A Rosenberg, Shanna V Diaz, Sarah E Pirio Richardson, Henry C Lin

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    27 Downloads (Pure)

    Abstract

    Cerebrovascular activity is not only crucial to optimal cerebral perfusion, but also plays an important role in the glymphatic clearance of interstitial waste, including α-synuclein. This highlights a need to evaluate how cerebrovascular activity is altered in Lewy body diseases. This review begins by discussing how vascular risk factors and cardiovascular autonomic dysfunction may serve as upstream or direct influences on cerebrovascular activity. We then discuss how patients with Lewy body disease exhibit reduced and delayed cerebrovascular activity, hypoperfusion, and reductions in measures used to capture cerebrospinal fluid flow, suggestive of a reduced capacity for glymphatic clearance. Given the lack of an existing framework, we propose a model by which these processes may foster α-synuclein aggregation and neuroinflammation. Importantly, this review highlights several avenues for future research that may lead to treatments early in the disease course, prior to neurodegeneration. © 2024 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

    Original languageEnglish
    Pages (from-to)1258-1268
    Number of pages12
    JournalMovement Disorders
    Volume39
    Issue number8
    Early online date30-May-2024
    DOIs
    Publication statusPublished - Aug-2024

    Fingerprint

    Dive into the research topics of 'Abnormal Cerebrovascular Activity, Perfusion, and Glymphatic Clearance in Lewy Body Diseases'. Together they form a unique fingerprint.

    Cite this